Fusion Antibodies Revenue Growth & History (FAB)

Fusion Antibodies reported £2.0M in revenue for fiscal 2025, an increase of 72.98% from the previous fiscal year.

View full Fusion Antibodies company overview

Fusion Antibodies annual revenue and growth

Fusion Antibodies annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-03-31£2.0M£829,000+72.98%
20242024-03-31£1.1M−£1.8M−60.84%
20232023-03-31£2.9M−£1.9M−39.55%
20222022-03-31£4.8M

Fusion Antibodies revenue growth trends

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review Fusion Antibodies source filings ↗

Community posts

It’s quiet here.

No posts about FAB yet. Start the conversation.

Write the first post